Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Vitamin B supplements may reverse grey hair.

Effective alopecia treatment depends on the specific cause and includes medications and procedures.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

This type of hair loss is probably often missed and treatments reducing inflammation might work well.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

Topical antibiotics successfully treated a rare scalp condition in an elderly man with vitiligo.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

A man had a rare skin cancer that looked like a bald spot.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

A woman with ectopic Cushing's syndrome and COVID-19 passed away despite treatment.

Estrogen deficiency can reduce the enzyme activity needed to activate vitamin D.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.